Skiplink Navigation

Main Features

Income up but outlook less optimistic at Unilabs

The Geneva-based clinical laboratory testing group, Unilabs, says interim net profit was 16 per cent higher at SFr6.5 million ($4 million) over the six months to November last year.

The group says the acceleration of growth in the second half of its financial year is down to strong internal expansion and the start of new hospital laboratory contracts.

It expects full year revenue to rise by 15 to 20 per cent to between SFr190 and SFr200 million.

However, shares in the group have come under pressure on the Swiss bourse because the forecast profit is slightly lower than expected.

The company put this down to the delayed start of Spanish hospital contracts.

swissinfo with agencies


Neuer Inhalt

Horizontal Line

subscription form

Form for signing up for free newsletter.

Sign up for our free newsletter and get the top stories delivered to your inbox.

swissinfo EN

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

Join us on Facebook!